EP0689595B1 - Promoteur vegetal, microorganismes et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur - Google Patents
Promoteur vegetal, microorganismes et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur Download PDFInfo
- Publication number
- EP0689595B1 EP0689595B1 EP94911205A EP94911205A EP0689595B1 EP 0689595 B1 EP0689595 B1 EP 0689595B1 EP 94911205 A EP94911205 A EP 94911205A EP 94911205 A EP94911205 A EP 94911205A EP 0689595 B1 EP0689595 B1 EP 0689595B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sequence
- plant
- promoter
- seq
- plants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 108
- 102000004169 proteins and genes Human genes 0.000 title claims description 51
- 230000014509 gene expression Effects 0.000 title claims description 50
- 244000005700 microbiome Species 0.000 title claims description 8
- 230000000694 effects Effects 0.000 claims description 66
- 241000894006 Bacteria Species 0.000 claims description 17
- 238000011144 upstream manufacturing Methods 0.000 claims description 10
- 230000001939 inductive effect Effects 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 6
- 230000003032 phytopathogenic effect Effects 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 5
- 241000238631 Hexapoda Species 0.000 claims description 3
- 241000244206 Nematoda Species 0.000 claims description 2
- 230000037125 natural defense Effects 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 description 159
- 108010060309 Glucuronidase Proteins 0.000 description 77
- 244000061176 Nicotiana tabacum Species 0.000 description 62
- 102000053187 Glucuronidase Human genes 0.000 description 59
- 238000010276 construction Methods 0.000 description 56
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 54
- 108020004414 DNA Proteins 0.000 description 46
- 235000018102 proteins Nutrition 0.000 description 46
- 239000013598 vector Substances 0.000 description 44
- 239000013612 plasmid Substances 0.000 description 43
- 239000002609 medium Substances 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 38
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 238000000034 method Methods 0.000 description 28
- 239000002299 complementary DNA Substances 0.000 description 27
- 239000000203 mixture Substances 0.000 description 26
- 210000001938 protoplast Anatomy 0.000 description 26
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 20
- 230000004913 activation Effects 0.000 description 18
- 239000011780 sodium chloride Substances 0.000 description 18
- 241000589771 Ralstonia solanacearum Species 0.000 description 17
- 108020004707 nucleic acids Proteins 0.000 description 17
- 102000039446 nucleic acids Human genes 0.000 description 17
- 150000007523 nucleic acids Chemical class 0.000 description 17
- 239000005712 elicitor Substances 0.000 description 16
- 238000011081 inoculation Methods 0.000 description 16
- 230000010474 transient expression Effects 0.000 description 16
- 240000002791 Brassica napus Species 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 15
- 239000000872 buffer Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 14
- 239000012634 fragment Substances 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 13
- 230000006698 induction Effects 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 13
- 229930027917 kanamycin Natural products 0.000 description 13
- 229960000318 kanamycin Drugs 0.000 description 13
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 13
- 229930182823 kanamycin A Natural products 0.000 description 13
- 239000000725 suspension Substances 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 230000009466 transformation Effects 0.000 description 13
- 108010022172 Chitinases Proteins 0.000 description 12
- 230000035939 shock Effects 0.000 description 12
- 102000012286 Chitinases Human genes 0.000 description 11
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 238000012217 deletion Methods 0.000 description 10
- 230000037430 deletion Effects 0.000 description 10
- 210000002257 embryonic structure Anatomy 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 10
- 230000009261 transgenic effect Effects 0.000 description 10
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 10
- 229910052721 tungsten Inorganic materials 0.000 description 10
- 239000010937 tungsten Substances 0.000 description 10
- 244000020551 Helianthus annuus Species 0.000 description 9
- 206010020649 Hyperkeratosis Diseases 0.000 description 9
- 108091034057 RNA (poly(A)) Proteins 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 208000035143 Bacterial infection Diseases 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 208000022362 bacterial infectious disease Diseases 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000013604 expression vector Substances 0.000 description 8
- LIIALPBMIOVAHH-UHFFFAOYSA-N herniarin Chemical compound C1=CC(=O)OC2=CC(OC)=CC=C21 LIIALPBMIOVAHH-UHFFFAOYSA-N 0.000 description 8
- JHGVLAHJJNKSAW-UHFFFAOYSA-N herniarin Natural products C1CC(=O)OC2=CC(OC)=CC=C21 JHGVLAHJJNKSAW-UHFFFAOYSA-N 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- ZLQJVGSVJRBUNL-UHFFFAOYSA-N methylumbelliferone Natural products C1=C(O)C=C2OC(=O)C(C)=CC2=C1 ZLQJVGSVJRBUNL-UHFFFAOYSA-N 0.000 description 8
- 239000011859 microparticle Substances 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 240000008042 Zea mays Species 0.000 description 7
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 6
- 235000003222 Helianthus annuus Nutrition 0.000 description 6
- 235000007340 Hordeum vulgare Nutrition 0.000 description 6
- 240000005979 Hordeum vulgare Species 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 229960004261 cefotaxime Drugs 0.000 description 6
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000008223 sterile water Substances 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229930192334 Auxin Natural products 0.000 description 5
- 108010042407 Endonucleases Proteins 0.000 description 5
- 102000004533 Endonucleases Human genes 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000011543 agarose gel Substances 0.000 description 5
- 239000002363 auxin Substances 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000035784 germination Effects 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- 241000589158 Agrobacterium Species 0.000 description 4
- 108091035707 Consensus sequence Proteins 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 241000561282 Thielaviopsis basicola Species 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 229950006238 nadide Drugs 0.000 description 4
- 108010058731 nopaline synthase Proteins 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 241001149961 Alternaria brassicae Species 0.000 description 3
- 235000011293 Brassica napus Nutrition 0.000 description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 3
- 241000701489 Cauliflower mosaic virus Species 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 241001131785 Escherichia coli HB101 Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 101710149086 Nuclease S1 Proteins 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000009418 agronomic effect Effects 0.000 description 3
- 244000000005 bacterial plant pathogen Species 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- 235000021186 dishes Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000001744 histochemical effect Effects 0.000 description 3
- 239000000411 inducer Substances 0.000 description 3
- 229960000367 inositol Drugs 0.000 description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 238000004382 potting Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000010473 stable expression Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 239000010455 vermiculite Substances 0.000 description 3
- 235000019354 vermiculite Nutrition 0.000 description 3
- 229910052902 vermiculite Inorganic materials 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 101150111062 C gene Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 2
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- 208000034693 Laceration Diseases 0.000 description 2
- 241001625930 Luria Species 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 240000002769 Morchella esculenta Species 0.000 description 2
- 235000002779 Morchella esculenta Nutrition 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000813090 Rhizoctonia solani Species 0.000 description 2
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000016571 aggressive behavior Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000003816 axenic effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- ZYWFEOZQIUMEGL-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol;phenol Chemical compound ClC(Cl)Cl.CC(C)CCO.OC1=CC=CC=C1 ZYWFEOZQIUMEGL-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-O cyclohexylammonium Chemical compound [NH3+]C1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-O 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000003415 peat Substances 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-DOMIDYPGSA-N 2-(2,4-dichlorophenoxy)acetic acid Chemical compound OC(=O)[14CH2]OC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-DOMIDYPGSA-N 0.000 description 1
- ARQXEQLMMNGFDU-JHZZJYKESA-N 4-methylumbelliferone beta-D-glucuronide Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ARQXEQLMMNGFDU-JHZZJYKESA-N 0.000 description 1
- PZUPAGRIHCRVKN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-5-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound OCC1OC(O)C(O)C(O)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(COC4C(C(O)C(O)CO4)O)O3)O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(COC2C(C(O)C(O)CO2)O)O1 PZUPAGRIHCRVKN-UHFFFAOYSA-N 0.000 description 1
- DHJFFLKPAYHPHU-BYNIDDHOSA-N 5-bromo-4-chloro-3-indolyl beta-D-glucuronide Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 DHJFFLKPAYHPHU-BYNIDDHOSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102100027150 Ankyrin repeat and SAM domain-containing protein 4B Human genes 0.000 description 1
- 101710165990 Ankyrin repeat and SAM domain-containing protein 4B Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- HSSBORCLYSCBJR-UHFFFAOYSA-N Chloramben Chemical compound NC1=CC(Cl)=CC(C(O)=O)=C1Cl HSSBORCLYSCBJR-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
- 239000005504 Dicamba Substances 0.000 description 1
- 241000588694 Erwinia amylovora Species 0.000 description 1
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 101000617707 Homo sapiens Pregnancy-specific beta-1-glycoprotein 11 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Natural products SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N L-Serine Natural products OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-Tryptophan Natural products C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010024774 Localised infection Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101500006448 Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) Endonuclease PI-MboI Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102100022023 Pregnancy-specific beta-1-glycoprotein 11 Human genes 0.000 description 1
- 241000549435 Pria Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000000211 autoradiogram Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- -1 ethylene (Roby et al Chemical class 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940064880 inositol 100 mg Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- HJRIWDYVYNNCFY-UHFFFAOYSA-M potassium;dimethylarsinate Chemical compound [K+].C[As](C)([O-])=O HJRIWDYVYNNCFY-UHFFFAOYSA-M 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 229940098524 pyridoxine 1 mg Drugs 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000003584 silencer Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000020138 yakult Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8239—Externally regulated expression systems pathogen inducible
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/8223—Vegetative tissue-specific promoters
- C12N15/8227—Root-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/8223—Vegetative tissue-specific promoters
- C12N15/8229—Meristem-specific, e.g. nodal, apical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
Definitions
- the subject of the present invention is a new plant promoter and microorganisms and plant cells containing a unit expression of a protein of interest comprising said promoter.
- the promoter according to the invention is a strong constitutive promoter allowing an expression of said protein in microorganisms and plant cells whatever the stage of development of the plant.
- the promoter according to the invention finds an application particular in the field of plant protection by engineering genetics and in particular that of the defense of plants under stress.
- the genes that were introduced by genetic engineering in plants are chimerical, combining regulatory elements of different origins. This is how very often the gene encoding a protein of interest is placed under the control of a strong constitutive promoter allowing expression of said protein throughout the plant (or most of it) throughout its life, whatever the stage of development.
- the promoter of the cauliflower mosaic virus 35S transcript (35S CaMV) the most used in the construction of chimeric genes, fits this description.
- a plant promoter isolated from tobacco has been described by Takahashi and al., Proc. Natl. Acad. Sci. USA, 1990, 87, 8013-8016.
- the present invention relates to a promoter, which is expressed to a sustained level in the various organs and tissues of a plant and in particular the roots and meristem of a plant and that is very highly inducible in stressful situations, such as in particular after thermal shock, injury, hormonal shock, elicitor biotic or abiotic or a bacterial, fungal or viral infection.
- the invention also relates to plant cells with the exception naturally occurring plant cells, microorganisms (bacteria) and cells of microorganisms that have integrated a unit expression of a protein of interest, said unit comprising the promoter according to the invention.
- It also relates to plants or parts of plants as well as the seeds which include the plant cells of the invention.
- the promoter according to the invention comprises the DNA sequence (B) [SEQ ID NO: 4] or a sequence with a degree of homology of at least minus 80% with the sequence (B).
- the promoter according to the invention comprises, in upstream of the sequence (B), a sequence (C) [SEQ ID NO: 5] or a sequence having a high degree of homology with the sequence (C).
- the promoter of the invention comprises, upstream of the sequence (B), a sequence (D) [SEQ ID NO: 6] or a sequence with a high degree of homology with the sequence (D).
- a high degree of homology here means a homology (relation between identical nucleotides and the total number of nucleotides) of at least minus 70%. and preferably at least 80%, sequences of nucleotides, when aligned according to maximum homology, according to the optimal alignment method of the sequences of Needleman and Wunsch. 1970; J. Mol. Biol., 48, 443-453. This method is notably used in UWGCG software from the University of Wisconsin: Devereux et al., 1984, Nucl. Ac. Res., 12, 387-395 - GAP option.
- This promoter The elements necessary for the operation of this promoter and the expression of its characteristics (transactivating factors, etc.) are present in other plants, dicots or monocots. Their presence therefore allows the use of this promoter in many cultivated plants, such as in particular plants (tobacco, potato, tomato, corn, sunflower, barley and rapeseed) or other plants, such as yeasts and mushrooms.
- Any DNA sequence encoding proteins of interest can be placed under the control of the promoter according to the invention, in particular sequences coding for proteins which allow protect a plant, for example a plant against viral, bacterial or fungal infections and against other conditions of stress.
- sequences coding for proteins which allow protect a plant for example a plant against viral, bacterial or fungal infections and against other conditions of stress.
- tomato-tobacco endochitinases such as that described in EP-A-493 581 whose coding sequence is [SEQ ID NO: 16].
- the promoter according to the invention was obtained by screening for a tobacco genomic library using a DNA probe having the sequence [SEQ ID NO: 1].
- a clone corresponding to the sequence [SEQ ID NO: 1] was obtained by differential screening of cDNA clones derived from poly (A) + mRNA, specifically synthesized during the infection of Nicotiana tabacum tobacco leaves by strain of Pseudoaonas solanacearum GMI 1000. This bacterial strain is well known to cause a hypersensitivity reaction on tobacco of the special Bottom variety . For this purpose, one can refer to the work Message et al, 1978. Proc. 4th. Intl. Conf. of plant Pathogenic Bacteria pp. 823-833. The clone containing the sequence [SEQ ID NO: 1] will hereinafter be called "clone 246".
- Clone 246 then made it possible, by screening a genomic library tobacco to isolate a clone, hereinafter called clone 246 C [SEQ ID NO: 7]. which contains the DNA sequence (D) [SEQ ID NO: 6], the DNA sequence (C) [SEQ ID NO: 5], the DNA sequence (B) [SEQ ID NO: 4] and a sequence containing 2 open reading frames separated by an intron.
- sequences B + C + D By association of the promoter (sequences B + C + D) with the gene for ⁇ -glucuronidase was obtained, according to the procedure described in section 9 below, the expression vector pSG 123.
- the promoter consisting of B + C + D sequences is called the 246C promoter.
- the expression vector pSG 123 was used to test the transient expression in tobacco protoplasts of the glucuronidase gene, said protoplasts being placed under stress either by infection with Pseudomonas solanacearum or by treatment using 'an elicitor or hormone.
- This binary vector pSG 246 was transferred into cells of Agrobacterium tumefaciens or Agrobacterium rhizogenes, which were then used to obtain transgenic plants of tobacco, rapeseed and sunflower.
- Agrobacterium tumefaciens or Agrobacterium rhizogenes were then used to obtain transgenic plants of tobacco, rapeseed and sunflower.
- the expression vector pSG 123 was used for the transformation of monocotyledonous tissues (barley and corn). We studied the behavior of these plants or tissues under stress.
- the promoter according to the invention comprising the sequence (B), (C) and (D) has also been associated with the gene coding for tomato-tobacco chitinase.
- the resulting chimeric genes were used to transform Agrobacterium cells .
- the DNA sequence [SEQ ID NO: 1] can easily be synthesized according to techniques well known to those skilled in the art (L.J. Mac PRIDE and H.M. CARUTHURS Tetrahydron letters (1983) vol. 24: 245).
- transgenic plants obtained by transformation of plants using Agrobacterium cells obtained above made it possible to demonstrate the basic promoter activity of the promoter according to the invention as well as the overexpression of the proteins of interest ( ⁇ -glucuronidase and chitinase) in stressful situations.
- the promoter according to the invention has an activity basic promoter which is greatly increased when plants transgenics containing this promoter and a gene coding for a protein of interest, are placed under stress conditions: thermal shock, injury, infection by pathogens (fungi, bacteria), elicitors (biotics and abiotics).
- the vectors pSG 251 and pSG 33 including the sequences are respectively the sequence (B) (pSG 33) [SEQ ID NO: 4] or the sequence (B) including upstream the sequence (C) (pSG 251) [SEQ ID NO: 5].
- Plants have defense mechanisms against aggression and especially parasitic aggressions (fungi, bacteria, viruses or insects) ; these mechanisms depend on induction phenomena are little known and often set up too late to be effective. Their early onset (Roby et al. 1988, Physiol. Molec. Plant. Pathol., 33. 409) in particular by elicitor-type compounds in cascade reactions allows the plant to resist assaults.
- Second generation fungicides active on the defenses of the plant while being inactive on the parasite have already been put on the market.
- FIG. 1 represents the mapping of the genomic DNA clone 246C, established using the restriction enzymes shown.
- Figure 2 shows alignment using the alignment method optimal de Needleman et Wunsch, 1970, J. Mol., BIol., 48, 443-453 work by UWGCG software from the University of Wisconsin (Devereux and al., 1984, Nucl. Ac. Res., 12, 387-395) GAP option, from part 3 'of 700 bp of the promoter of the 246C gene and of the promoter described by Takahashi and al., 1989, Proc. Natl. Acad. Sci. USA, 87, 8013).
- FIG. 3 represents the different expression vectors tested comprising, with respect to the full-length plasmid pSG123, a deletion promoter part variable 5 '.
- Section 1 Nicotiana tabacum tobacco infection with two strains of the pathogenic bacteria Pseudomonas solanacearum
- the bacteria of the Pseudomonas solanacearum strain are cultivated for 72 h on agar BG medium (Boucher et al. 1985. J. Gen Microbiol 131, 2449); a colony is taken to inoculate 40 ml of the same medium. After 16 to 24 h incubation at 28 ° C. the bacterial suspension is centrifuged for 10 min at 6000 g and 4 ° C; the supernatant is removed while preserving the layer of polysaccharides present on the surface of the pellet. After washing with sterile water, the bacteria are resuspended in 20 ml of water. Their concentration is then determined by densitometry.
- Young leaves of tobacco plants are detached from the plant. washed with distilled water and immersed in a desiccator containing 1.2 l of bacterial suspension at the concentration of 3 x 10 6 bacteria / ml. The vacuum is created for 10 min using a vacuum pump, then it is slowly broken. Each infiltrated leaf is then placed in a beaker containing 10 mM sodium phosphate buffer pH 6.0 and transferred to a culture chamber. The leaves are removed after different incubation times and stored at - 70 ° C.
- Section 2 Extraction and isolation of total RNA from Nicotiana tabacum infected with Pseudomonas solanacearum strains
- the pellet obtained is dissolved in 5 ml of sterile water containing 0.1% of diethylpyrocarbonate (DEPC) then the RNAs are precipitated for 12 h at 4 ° C after addition of 5 ml of 4M LiCl. After a 20 min centrifugation at 6000 g, the RNA pellet is washed with 75% ethanol. dried and taken up in 800 ⁇ l of sterile distilled water containing 0.1% DEPC. The solution is precipitated for 2 h at -20 ° C. after the addition of 0.1 vol of 3M sodium acetate pH 5.5 and 2.5 vol of absolute ethanol.
- DEPC diethylpyrocarbonate
- RNA pellet After centrifugation for 15 min at 12,000 g, the RNA pellet is washed with 75% ethanol and dissolved in 200 ⁇ l of distilled water containing 0.1% DEPC. The total RNAs are then assayed by spectrophotometry at 260 nm.
- Section 3 Preparation of poly (A) + messenger RNAs
- oligo-d (T) cellulose gel (Collaborative Research Inc.) is resuspended in 2 ml of 10 mM Tris-HCl buffer pH 7.4, 1 mM EDTA, 0.4 M NaCl, 0.1% SDS, This gel is introduced into a Pasteur pipette, the end is plugged with glass wool. The RNA solution is brought to 65 ° C for 4 min and then allowed to cool slowly at ambient temperature. A final concentration of 0.4 M in NaCl is obtained by addition of 5M NaCl solution.
- RNA solution is then deposited on the oligo-d gel (T) cellulose. This is then rinsed with approximately 12 ml of buffer.
- composition 10 mM Tris-HCl pH 7.4, 0.4 M NaCl, 1 mM EDTA, 0.5% SDS.
- the poly (A) + RNAs are then eluted using 7 ml of 10 mM Tris-HCl composition buffer, pH 7.4, 0.1 X SDS, then precipitated overnight at -20 ° C after addition of 2, 5 volumes of 95% ethanol and 0.1 volumes of 3.3 M sodium acetate pH 5.5.
- the poly (A) + RNA pellet obtained by centrifugation at 35,000 g for 1 h, is washed 3 times with 75% ethanol, dried, taken up in 0.5 ml of sterile distilled water and subjected to a new precipitation under the conditions described above. After centrifugation, the pellet is then washed with 75% ethanol, dried and dissolved in sterile distilled water.
- the poly (A) + RNAs are then assayed by spectrophotometry at 260 nm.
- Section 4 Synthesis of double-stranded DNA from poly (A) + messenger RNA isolated from tobacco leaves infected with the GMI 1000 strain of Pseudomonas solanacearum and cloning in E. coli .
- RNA isolated from tobacco leaves infected with the GMI 1000 strain of Pseudomonas solanacearum and collected 6 h after inoculation are incubated at 44 ° C. for 30 to 60 min in the presence of : Tris HCl 40 mM, pH 8.3, NaCl 80 mM, MgCl 2 6 mM, DTT 5 mM, dATP 0.5 mM, dTTP 0.5 mM, dGTP 0.5 mM, dCTP 0.5 mM, 1, 5 ⁇ g of oligo d (pT) 12-18 and 10 to 15 units of reverse transcriptase of AMV (airplane myeloblastosis virus) in a total volume of 25 ⁇ l.
- AMV airplane myeloblastosis virus
- the reaction medium resulting from the synthesis of the first strand is diluted to 100 ⁇ l using the composition buffer Tris HCl 40 mM pH 7.5, MgCl 2 10 mM, NaCl 80 mM; 2 units of RNase H are added and the mixture is incubated at 37 ° C for 5 min.
- the reaction is stopped by adding EDTA and SDS in concentrations 20 mM and 1% final, respectively, followed by 2 min heating at 60 ° C.
- the precipitate obtained is washed with 75% ethanol, dried and taken up in sterile water.
- the cDNA is then treated with nuclease S1 in a total volume of 300 ⁇ l, at 30 ° C. for 10 min, in the presence of 20 U of enzyme in the buffer of composition 30 mM sodium acetate pH 4.4, NaCl 0.25 M, ZnCl 2 1 mM.
- the mixture is extracted once by a mixture of Phenol-chloroform-isoamyl alcohol (50-48-2. V: V) then three times with ethyl ether before being subjected to precipitation with ethanol.
- the DNA precipitate obtained after centrifugation is then dried and taken up in 20 ⁇ l of sterile water.
- terminal transferase buffer of potassium cacodylate composition 70 mM pH 7.2, CoCl 2 0.5 mM, dithiothreitol 0.5 mM, 2 ⁇ l of ⁇ dCTP 0.25 mM, 5 ⁇ l of ⁇ 32P dCTP (370 MBq / ml), 12 ⁇ l of H 2 O and 1.2 ⁇ l of terminal transferase (18 units).
- the tailing reaction is carried out by incubation at 37 ° C. for 30 min, then stopped by adding 30 ⁇ l of EDTA, 0.25M pH 8.0.
- the mixture from dC tailing is precipitated with ethanol and then centrifugal.
- the cDNA pellet is taken up in 10 ⁇ l of buffer of composition Tris HCl 10 mM pH 7.5, NaCl 100 mM, EDTA 1 mM, 5% glycerol, 0.02% bromophenol blue. This solution is deposited on a column of Biogel A 0.5 M (1 ml of support). The column is eluted with the 10 mM Tris HCl composition buffer, pH 7.5, 100 mM NaCl, EDTA 1 mM; fractions are collected, their radioactivity measured, and the size of the cDNAs they contain is analyzed by electrophoresis on agarose gel. Fractions containing cDNAs larger than 500 base pairs are combined and the cDNA is precipitated by ethanol.
- the cDNA collected after precipitation is redissolved in 50 ⁇ l of circularization buffer with 20 mM Tris-HCl composition, pH 7.5. 100 mM NaCl, 1 mM EDTA. 4 ⁇ l of pBR 322-dG solution (21 ng, Clontech) and 46 ⁇ l of water are added.
- the double-stranded cDNA obtained is inserted at the PstI site of the plasmid pBR 322. After ligation, the DNA obtained is used to transform competent cells of the E. coli HB101 strain. Colonies of recombinant bacteria are obtained after spreading and culture on dish. Petri dishes of transformed competent cells.
- Section 5 Selection by differential screening of cDNA clones derived from poly (A) + mRNA specifically synthesized during bacterial infection with the strain of Pseudomonas solanacearum GMI 1000.
- the DNA of the recombinant bacterial colonies obtained by cloning of cDNA synthesized from poly (A) messenger RNA + from tobacco leaves infected with the GMI 1000 strain was transferred onto a Biodyne nylon membrane (Pall Corporation, EUA) following the manufacturer's instructions. These DNAs are successively hybridized using 2 radioactive probes obtained by cDNA synthesis, in the presence of alpha-32P dCTP, from purified messenger RNAs from plants infected with the strains GMI 1000 and GMI 1178 respectively.
- the bacterial colonies with a stronger hybridization signal with the probe synthesized from leaves inoculated with the strain GMI 1000 are selected.
- the plasmid DNA of these colonies is prepared, the cDNA inserts of these plasmids are isolated and then labeled with alpha 32-dCTP and are used as a probe to reveal according to the dot-blot technique then Northern blot the equivalent quantities of corresponding mRNA purified from total RNA, tobacco leaves inoculated with the GMI 1000 or GMI 1178 strain.
- 14 bacterial clones were isolated from the cDNA library constructed from messenger RNA from tobacco leaves infected with the Pseudomonas solanacearum GMI 1000 strain.
- a clone called 246. having a length 750 base pair insert allows Northern Blot to reveal a transcribed of approximately 800 nucleotides. The accumulation of this transcript begins 4 to 9 hours after inoculation, and reaches a maximum between 12 and 3 p.m. In tobacco leaves infected with the GMI 1178 strain, observe a slight accumulation of the transcript between 12 and 3 p.m.
- the study of the cDNA sequence of clone 246 [SEQ ID NO: 1] highlights the existence of a first incomplete open reading frame. encoding a peptide of 59 amino acids and a second potential framework encoding a peptide of 88 amino acids. The sequence of these two peptides is represented by [SEQ ID NO: 2]. Between these two reading frames, consensus sequences of intron splicing (Brown, 1986, Nucl. Ac. Res., 14, 9549) are present. There was therefore probably cloning of a cDNA from an immature messenger RNA. The cDNA sequence of clone 246 without the intron is the sequence A 1 [SEQ ID NO: 3].
- a tobacco DNA genomic library was obtained by partial digestion using the DNA enzyme MboI isolated from germination of Nicotiana tabacum variety NK 326, and cloning of the restriction fragments in the phage EMBL-3 (Clontech ). 500,000 recombinant phages were screened, after spreading at the rate of 10,000 phages per Petri dish according to the technique known to those skilled in the art and described in Sambrook et al (Molecular Cloning, A laboratory manual, Cold Spring Harbor Laboratory Press, 1989).
- the phage DNA is transferred onto a nitrocellulose membrane (BA 85 Schleicher and Schüll), denatured for 2 min in NaOH solution 0.5 M, 1.5 M NaCl, then soaked in NaCl neutralization solution 1.5 M, Tris HCl 0.5 M pH 7.4 for 5 min. After rapid rinsing in 2 SSC (0.3 M NaCl, 30 mM sodium citrate) the filters are dried 30 min at 37 ° C and the DNA is then fixed by treatment at 80 ° C under vacuum for 1h30.
- a nitrocellulose membrane BA 85 Schleicher and Schüll
- the membranes are then prehybridized for 4 h at 37 ° C. in a composition buffer 5 SSC (0.75 M NaCl, 75 mM sodium citrate), 50% formamide, 0.3% skim milk.
- Hybridization is carried out in the same buffer, for 18 h at 37 ° C. after addition of the probe labeled with alpha 32P-dCTP, consisting of the 750 base pair insert of cDNA clone 246.
- the membranes are then washed 3 times for 20 min at 37 ° C. in a solution 5 SSC, SDS 0.1%, then 2 times for 30 min at 37 ° C in a 2 SSC solution, 0.1% SDS and finally 30 min at 42 ° C in a 2 SSC solution, 0.1% SDS; they are then autoradiographed.
- phages are eluted in SM medium (100 mM NaCl, 50 mM Tris HCl, pH 7.5, 5 mM SO4 Mg, gelatin 0.01%) then purified by a new screening carried out in the same conditions.
- SM medium 100 mM NaCl, 50 mM Tris HCl, pH 7.5, 5 mM SO4 Mg, gelatin 0.01%
- Section 8 Sequencing and sequence analysis of the genomic DNA clone 246C
- This insert called 246C genes, of 3046 base pairs, is consisting of an 853 bp coding region starting with an ATG in position 2146 and terminated by a TGA codon at position 2998; this region is interspersed with an intron beginning at position 2464 and ending in position 2653.
- Three potential sites for initiating transcription were determined by primer extension according to the technique described in Sambrook et al. (opus cited, 1989), the most likely site is in position 2068.
- the promoter region of the 246C gene upstream of position 2146 is called promoter 246C.
- Study of the 246C promoter sequence shows the presence of several reasons known to be involved in the gene regulation.
- Two TATAA consensus sequences are present at positions 2089 and 2111 as well as an AATAT complementary sequence at position 2020. These three patterns are all located between 10 and 50 base pairs downstream of the CAAT assets and 30 to 50 base pairs upstream of the potential transcription.
- TGACG sequence has been identified at position 1950; this sequence demonstrated in the CaMV 35S promoter, seems responsible for the expression of chimeric genes in the roots and in the leaves (LAM et al. 1989, Proc Natl Acad Sci USA, 86, 7890).
- HSE Heat Shock Elements
- TTCNNTTCNNGAANNGAA Three regions show significant homogeneity with the patterns HSE (Heat Shock Elements) of plants (GURLEY and KEY, 1991, Biochemistry, 30. 1). These regions are homologous with the consensus sequence GAANNGAANNTTCNNTTC or TTCNNTTCNNGAANNGAA; they are close to the boxes TATA and CAAT and duplicated [SEQ ID NO: 17 and NO: 18].
- FIG. 2 shows the alignment of the DNA sequence of this promoter [SEQ ID NO: 9, 10 and 11] (top line) with the part corresponding to the DNA sequence of the promoter of the invention [SEQ ID NO: 12 and 13] (bottom line).
- Section 9 Construction of the expression vector pSG123 associating the promoter of the 246C gene to the ⁇ -glucuronidase gene.
- the plasmid pBI 101.3 (Clontech) is digested with the enzymes HindIII and EcoRI; the fragment of approximately 2100 base pairs, containing the ⁇ -glucuronidase gene encoded by the uidA locus of E. coli , followed by the terminator of the nopaline synthase of Agrobacterium tumefaciens, is ligated in the plasmid pUC 19, open to the same sites, giving a plasmid called plasmid pBI 201.3.
- the HindIII-BalI insert carrying the promoter sequences of the gene 246C is cloned into the plasmid pBI201.3 open to the HindIII and Smal.
- the vector obtained called pSG 123 therefore contains the gene for glucuronidase under the control of the promoter of the 246C gene.
- the sequence nucleotide of the complete chimeric gene is the sequence [SEQ ID NO: 14].
- Section 10 Protocol of transient expression in protoplasts tobacco of the glucuronidase gene under the control of promoter of the 246C gene.
- Leaves from tobacco plants ( Nicotiana tabacum , var Samsun NN), 4 to 5 weeks old are removed, cut into strips and incubated in TO medium (Table 1, adapted from Chupeau et al., 1974, CR Acad Sci ( Paris), 278 D, 1565) containing 1 g / liter of cellulase R 100 Onozuka, 200 mg / l of macerozyme Onozuka (Yakult Honsha, Nishinoniya, Japan) and 500 mg / l of pectolyase Y23 (Sheishin Pharmaceutical Ind. Japan) for 3 p.m. at 22 ° C.
- the protoplasts are separated from the cell debris by sieving on a 85 ⁇ m mesh nylon sieve followed by centrifugation for 5 min at 50 g on a 19% sucrose solution (weight / volume).
- the protoplasts floating on this medium are washed once in the TO medium, counted and their number adjusted to the density of 1.5 ⁇ 10 6 protoplasts / ml.
- the E. coli strain containing the vector pSG 123 is cultured on Luria medium (Gibco) containing 50 mg / l of ampicillin. Amplification of the plasmid is carried out according to the protocol described in Sambrook et al., 1989 (opus cited). The plasmid pSG 123 is then purified by centrifugation on a cesium chloride gradient and by two successive precipitations with ethanol. The plasmid pellet is then redissolved in 10 mM Tris-HCl buffer, pH 8.0.
- the protoplast suspensions (320 ⁇ l per aliquot) are incubated at 45 ° C for 5 min, then quickly cooled on ice. Then 50 ⁇ g of plasmid pSG123, 160 ⁇ l of a polyethylene glycol solution (40% polyethylene glycol, 0.4 M mannitol, 30 mM MgCl 2 , 0.1% My pH 5.8) are then added. After 10 min, the protoplasts are collected by centrifugation and resuspended by gentle agitation in 500 ⁇ l of T0 buffer and incubated in the dark & 28 ° C.
- a polyethylene glycol solution 50% polyethylene glycol, 0.4 M mannitol, 30 mM MgCl 2 , 0.1% My pH 5.8
- protoplasts are lysed after addition of 50 ⁇ l of 10X extraction buffer for ⁇ -glucuronidase per freezing at -80 ° C followed by thawing at 37 ° C (Jefferson, 1987, Plant Molec. Biol. Reporter, 5, 387).
- the supernatant obtained after centrifugation at 10,000 g is used to measure ⁇ -glucuronldase activity by fluorimetry (Jefferson, 1987, Plant Molec. Biol. Reporter, 5, 387).
- the quantity of proteins present in the extracts is measured according to the Bradford method using the Bio Rad kit (Bio Rad. Lab.).
- Composition of TO medium for 1 liter) NH 4 NO 3 825 mg K NO 3 950 mg CaCl 2 , 2H 2 O 220 mg Mg SO 4 , 7H 2 O 185 mg KH 2 PO 4 85 mg H 3 BO 3 1 mg Mn SO 4 , 4H 2 O 100 ⁇ g Zn SO 4 , 7H 2 O 1 mg Kl 100 ⁇ g AlCl 3 30 ⁇ g NiCl 2 , 6H 2 O 30 ⁇ g CuSO 4 , 5H 2 O 30 ⁇ g Fe SO 4 , 7H 2 O 27.8 mg Na 2 EDTA, 2H 2 O 37.2 mg thiamin 100 ⁇ g Ac.
- MES ethanesulfonic acid
- Section 11 Transient expression of the glucuronidase gene under the control of the promoter of the 246C gene in tobacco protoplasts infected with Pseudomonas solanacearum.
- This transient expression is measured after incubation for 24 h of the protoplasts prepared according to the above protocol in the TO medium (described in section 10) containing a suspension of bacteria Pseudomonas solanacearum (10 bacteria / protoplast) obtained as described in section 1.
- ⁇ -glucuronidase activity is expressed in pmoles of methylumbelliferone formed / min / mg protein.
- the promoter of the 246C gene therefore allows basal expression important of the glucuronidase gene, expression more important than that ordered by the CaMV 35S promoter, which serves here as a control.
- This promoter also has strong inducibility since ⁇ -glucuronidase expression increases by 40% after infection with the bacterial strain GMI 1000.
- Section 12 Transient expression of the glucuronidase gene under control of the promoter of the 246 C gene of protoplasts tobacco treated by an elicitor (heptasaccharides chitin) or a hormone.
- Expression is measured after incubation of protoplasts for 24 h as described above in the TO medium containing an elicitor at the concentration of 25 ⁇ M or a hormone, 2-4-D (2-4 acid dichlorophenoxyacetic) at a concentration of 4 ⁇ M.
- the elicitors used are chitin heptasaccharides having the property of inducing defense reactions in plants (Roby et al., 1987, BBRC, 143, 885).
- Protoplasts which have received DNA from the vector pSG 123 have an activity of 450 pmol / min / mg of protein; this activity is increased 50% if the protoplasts are treated with the 2-4-D hormone and 70% if the protoplasts are treated with chitin heptasaccharide.
- Section 13 Construction of a stable expression vector in plant cells: the binary vector pSG246
- the vector obtained is cloned into the strain E. coli DH5 ⁇ .
- Section 14 Transfer into Agrobacteriu m of the plasmid pSG246 containing the ⁇ -glucuronidase under the control of the promoter of the tobacco 246C gene
- Competent cells of Agrobacterium tumefaciens (strain LBA 4404, Clontech) are prepared by rapid cooling in ice of a culture in the exponential growth phase. The bacteria are then resuspended in 20 mM CaCl 2 . Aliquots of this suspension are distributed in Eppendorf tubes, then frozen in liquid nitrogen.
- plasmid pSG246 1 ⁇ g of plasmid pSG246 is added to the frozen cells, contained in an Eppendorf tube. The suspension is then incubated at 37 ° C for 5 min; 1 ml of Luria medium (Gibco) is then added and the tube is incubated at 28 ° C for 4 h. Aliquots are spread on Petri dishes containing a minimum agar medium, described in Plant Molecular Biology Manual (op. Cited) in the presence of 100 mg of rifan-picine and 25 mg / l of kanamycin. Under these conditions, only the colonies of Agrobacterium tumefaciens which have integrated the plasmid pSG246 grow. These contain the chimeric gene in a context allowing its replication.
- the resistance to the two antibiotics of the selected colonies is checked by subculturing them on the same selection medium twice in succession.
- the presence of the chimeric gene associate the promoter 246 C with the coding part of ⁇ -glucuronidase in Agrobacterium tumefaciens is verified by the method of Southern Blot on a preparation of total DNA (Lysis of cells, purification of DNA by extraction with using the phenol / chloroform mixture, according to the protocol described by Gelvin in the work cited above, cutting the purified DNA using restriction enzymes, electrophoresis on agarose gel, transfer to membrane and hybridization according to techniques well known to those skilled in the art).
- Section 15 Obtaining tobacco plants transformed with Agrobacterium tumefaciens containing the plasmid pSG246.
- Nicotiana tabacum tobacco grown in vitro was infected with Agrobacterium tumefaciens containing the plasmid pSG246 according to the procedure of Horsch et al., Well known to those skilled in the art (Horsch RB et al., 1985, Science 227, 1229-1231) , the main steps of which are set out below.
- Discs of leaves of axenic tobacco plants Nicotiana tabacum are incubated in a culture of A. tumefaciens hosting the plasmid pSG246.
- the discs drained on Whatman paper are transferred to culture media in Petri dishes in order to multiply the transformed cells so as to obtain calluses (Murashige and Skoog, 1962, Physiol., Plant., 15, 473), then produce buds in the presence of cefotaxime (500 ⁇ g / ml) intended to eliminate Agrobacterium tumefaciens and kanamycin (100 ⁇ g / ml).
- the kanamycin-resistant buds were then transferred on a medium allowing the induction of the roots in the presence of carbenicillin and kanamycin.
- the seedlings are then transplanted in terrines in a substrate composed of peat and potting soil and grow in a greenhouse. All transformed plants (RO generation) having survived the stages of greenhouse regeneration and acclimatization shown to be morphologically normal and fertile. They have been self-fertilized and gave seeds (generation R1).
- Section 16 Analysis of the genomic DNA of tobacco plants transformed by Agrobacterium tumefaciens containing the plasmid pSG246 (generation RO), according to the technique of Southern Blot.
- High molecular weight tobacco genomic DNA was isolated from from mature leaves of transgenic plants of the RO generation according to the extraction method using bromide cetyltrimethylammonium and purification by precipitation, described in the work "Plant Molecular Biology Manual” already cited.
- a localized bacterial infection is carried out by depositing a drop of bacterial suspension of Pseudomonas solanacearum (3 ⁇ l containing 3 ⁇ 10 5 bacteria obtained as described in section 1) on a wound obtained by perforating a sheet using a syringe needle.
- the 246C promoter is activated around the lesion created by Infection and also in all parts of the infected plant (inoculated leaf, upper leaves and lower leaves of the plant and roots). This systemic activation occurs as soon as first hours after Inoculation.
- 20 mm diameter leaf discs from plants expressing the construction pSG246 are placed in survival on an appropriate liquid medium.
- On each of these discs is placed an agar cube of approximately 5mm side and containing mycelium of Sclerotinia Sclerotiorum .
- Glucuronidase activity measured as a function of time, reveals that the presence of mycelium induces glucuronidase activity after 7 hours of contact. After 24 hours, the activity is multiplied by 4 compared to that of leaf discs not brought into contact with the mycelium.
- the same experiment carried out on leaf discs obtained from control tobaccos (not expressing the construction pSG246) reveals only a glucuronidase activity comparable to a background noise.
- Two types of elicitor were used, one of the biotic type corresponding to molecules derived from molecules or macromolecules natural, the other of abiotic type corresponding to molecules chemical.
- the growers used are harp which is a protein isolated from Erwinia amylovora and a protein isolated from the culture supernatant of Pseudomonas solanacearum.
- protein elicitors such as cryptogeine isolated from Pseudomonas cryptogea and capsicin isolated from Pseudomanas capsict (Ricci et al. 1989, Eur. J. Biochem. 183; 555-563) were tested.
- induction activity in all cases is induced by the presence of elicitor in a ring of approximately 5mm immediately adjacent to the infiltration zone. The stimulation is very apparent 24 hours after the infiltration but visible from 6 a.m. Activity after 24 hours is often multiplied by 5 to 6 compared to those of control plants (plants expressing the construction pSG246 but without elicitors injected under the epidermis).
- Tobacco leaves expressing the construction pSG246 and detached of the plant are immersed in solutions of concentration 1 to 10 ⁇ g / ml salicylic acid or 0.025 to 0.25 mM copper sulfate.
- glucuronidase activity is multiplied by 5 after 6 hours and by 10 after 24 hours.
- glucuronidase activity is multiplied by 17 at 0.025 mM and 11 at 0.25 mM when compared to plant leaves untreated witnesses.
- auxin in the form of 2,4-dichlorophenoxyacetic acid (2,4-D) was performed at concentrations of 1.5 and 10 ⁇ M.
- Glucuronidase activity is measured at the onset of symptoms of the disease, approximately 15 days after inoculation.
- Tobacco plants, generation R1, containing the construction pSG246, about 5 weeks old and previously selected for their resistance to kanamycin are transferred for 2 or 4 h in an enclosure at 40 ° C in order to cause a thermal shock.
- the plants are immediately frozen in liquid nitrogen and their ⁇ -glucuronidase activity determined over the whole of the part Aerial.
- plants containing the pSG246 construct have a strong increase in glucuronidase activity after heat shock; the average stimulation factor, determined on several plants, is close to 12.
- Section 18 Obtaining rapeseed plants transformed by Agrobacterium rhizogenes containing the plasmid pSG246.
- Stem segments are taken from the apex of rapeseed plants ( Brassica napus : spring varieties Brutor and Westar and winter variety) about 1 m high. These segments are surface sterilized, rinsed in sterile water, cut into segments approximately 1.5 cm long and placed in a tube containing medium A.
- the end of this segment is inoculated by depositing a suspension of the Agrobacterium rhizogenes strain containing the plasmid psG 246.
- Transformed roots appear on the stem segment at after 1 to 2 weeks, they are removed and placed on medium B agar (15 g / l) and supplemented with 500 ⁇ g of cefotaxime / ml.
- Root fragments are incubated for 15 days in medium D containing 3 mg / l of 2,4-dichlorophenoxyacetic acid, then placed on the RCC medium for induction of buds. Rooted plants are then obtained by passing the buds over media F and G.
- the leaves of R1 generation rapeseed plants, containing the glucuronidase under the control of the 246C promoter were excised or excised and lacerated.
- R1 generation rapeseed plants having the construction pSG246, are cultivated for about 3 weeks in pots on potting soil. The plants are then inoculated locally using a spore suspension (10 ml, containing 1000 spores obtained after culture on the PDA agar medium) of the pathogenic fungus Alternaria brassicae , deposited on a wound produced using a needle. A necrosis then develops around this wound.
- a strong stimulation of glucuronidase activity is then observed (detected by test using X-gluc, Section 17e) in the sheet inoculated, around the necrotic area.
- Root pest Rhizoctonia solani
- R1 generation rapeseeds transformed by the construction pSG246 are sown on a substrate made of a mixture of peat, vermiculite and sand (10: 10: 5. v: v) contained in a 1 liter pot.
- the seeds are covered with a layer of 1 cm of substrate containing 10 000 viable propagules of Rhizoctonia solani per gram. These propagules are obtained by culture for 15 days of a strain of Rhizoctonia in a Roux flask on rice grains, followed by grinding to a particle size less than 1 mm.
- rapeseed plants are attacked at the root level.
- R1 generation rapeseed plants containing the construction pSG246, about 5 weeks old, are transferred for 2 or 4 h in an enclosure at 40 ° C to cause thermal shock.
- the plants are immediately frozen in liquid nitrogen and their ⁇ -glucuronidase activity determined over the whole of the part Aerial.
- plants containing the pSG246 construct have a strong increase in glucuronidase activity after heat shock; the average stimulation factor, determined on several plants, is close to 12.
- Section 20 Obtaining sunflower calluses transformed with Agrobacterium rhisogenes containing the plasmid pSG246.
- Sunflower hypocotyls are obtained by germination for 7 10 days of seeds on vermiculite. These seeds are placed in a culture chamber, the conditions 16 h of lighting at 20 ° C / 8 h darkness at 17 ° C. The hypocotyls are surface sterilized, rinsed in sterile water and placed in a tube containing medium Murashige and Skoog, whose concentration of macroelements is reduced by half.
- the end of this segment is inoculated by depositing a suspension of the Agrobacterium rhisogenes strain containing the plasmid pSG246.
- Transformed roots appear after a month, they are taken and placed on agar medium B (15 g / l) and supplemented per 500 ⁇ g cefotaxime / ml for 4 weeks with transplanting weekly. They are then cultivated in the same liquid medium in shaking (100 rpm) and transplanted every month. The passage of these roots in medium D, allows the formation of calluses from transformed roots.
- the glucuronidase activity of the roots cultivated in liquid medium B and of calli cultivated on medium D estimated by fluorimetry, has very high values, ranging between 10 4 and 10 5 pmoles of methylumbelliferone formed / min / mg of proteins.
- Section 21 Transient expression of the glucuronidase gene under 246C promoter control in embryos immature sunflower.
- Immature embryos of mother plants in the field of genotype 105 were collected and cultured for 14 days on medium I (Table 3) at 25 ° C and in the dark. These embryos are then cultivated for 3 days on Mileu II at 25 ° C under a photoperiod of 16 hours per day / 8 hours per night. About twenty embryos are then placed side by side on the middle III.
- Plasmid DNA is adsorbed on tungsten microparticles at a rate of 4 ⁇ g / mg of tungsten. 2.5mg of tungsten / DNA mixture are then deposited on a macroprojectile which is accelerated by the explosion of a cartridge.
- Macroprojectile crushing on a stop plate pierced with a hole projects tungsten microparticles and DNA into cells.
- Counting the number of blue cells obtained per box of Petri dish during a transient expression experiment allows count the number of transformed cells and estimate the expression of the chimeric construction tested.
- the transient expression measured using the substrate X-gluc., 48 hours after the bombardment using the microparticle cannon shows that the ⁇ -glucuronidase gene is expressed in embryos immature sunflower.
- the intensity is stronger than that induced by the use of plasmid pBI221 (Clontech), in which the glucuronidase gene is placed under the control of the cauliflower mosaic virus 35S promoter.
- the number of transformed cells expressing the gene for glucuronidase under the control of the promoter of the 246C gene is close to 140 per box (average value of 4 experiments) while the number of transformed cells is 60 per box (average value of 4 experiments) in the presence of the plasmid pBI221 in which the gene for glucuronidase is placed under the control of the 35 S promoter of the cauliflower mosaic.
- the embryos are then drained on sterile filter paper, then returned to culture on medium II in the dark for 3 days.
- the embryos are then briefly rinsed with Murashige and Skoog medium liquid (Murashige and Skoog, 1962, Physiol. Plant 15: 473) containing 500 mg / l of the cefotaxime antibiotic. They are then drained on sterile filter paper and cultured on medium III containing 250 mg / l cefotaxime. 250 mg / l of carbenicillin and 50 mg / l of paromomycin. This culture is carried out at 25 ° C. under a photoperiod of 16 h day / 8 h night; plant tissues are transplanted every 21 days on this same medium.
- the newly formed buds from these tissues are transferred to medium IV, under the same temperature and photoperiod conditions.
- the rooted plants are then grown in the greenhouse.
- Section 22 Expression of ⁇ -glucuronidase, under the control of the promoter 246C in transformed Sunflower plants.
- Plants expressing the construction pSG246 have an expression of glucuronidase at least equal to that obtained with plants transformed using the construction pBI121.
- nicotinic 1 - 1 0.5 0.5 Thiamine HCl 10 10 0.1 0.1 Pyridoxine HCl 1 1 0.1 0.5 Myo-inositol 4000 4000 100 100 L-glycine - - - 2 L-alanine 1000 1000 - - L-glutamine 800 800 - - L-serine 160 160 - - L-tryptophan 50 50 - - L-cysteine 10 10 - - Ca-D-pantothenate - - 0.8 - Ac. folic - - 0.1 - Chl.
- Section 23 Protocol of expression in monocot tissues of the ⁇ -glucuronidase gene, under the control of the promoter 246C
- GERBEL barley genotype seeds are germinated in a greenhouse on vermiculite. After 7 days, the leaves and roots were removed and placed on a Petri dish containing medium Murashige and Skoog agar for transient expression experiments.
- Immature corn embryos are removed 10 to 14 days after pollination from mother plants (line LH132) grown in the greenhouse. The embryos are placed on the embryonic axis side in contact with the medium induction (composition given in table 4 below) then on the maintenance medium (Table 5), 3 weeks later. Calls obtained are transplanted every week. Expression experiences transient are carried out a few hours after transplanting.
- Plasmid DNA is adsorbed on tungsten microparticles at a rate of 4 ⁇ g / mg tungsten. 2.5 mg of tungsten / DNA mixture are then deposited on a macroprojectile which is accelerated by the explosion of a cartridge.
- Macroprojectile crushing on a stop plate pierced with a hole projects tungsten microparticles and DNA into cells.
- Section 24 Transient expression of the ⁇ -glucuronidase gene under 246C promoter control in barley tissue and corn calluses
- the transient expression measured using the X-gluc substrate, 48 hours after the bombardment using the microparticle cannon shows that the ⁇ -glucuronidase gene is expressed in the leaves and barley roots and also in corn calluses.
- the intensity of the expression is as strong as that induced by the use of the plasmid pBI 221 (Clontech), in which the gene for glucuronidase is placed under the control of the 35S promoter of the cauliflower mosaic.
- the promoter of the tobacco 246C gene is therefore capable of directing gene expression in monocots.
- Section 25 Construction of a plasmid placing the chitinase gene tomato-tobacco under the control of the inducible promoter and expression of it in tobacco
- the plasmid pSG123 described above is digested using the endonucleases Hind III and Sca I. After electrophoresis on agarose gel, the Hind III - Sca I fragment of 2088 base pairs containing all of the inducible promoter with the exception of the 57 base pairs located immediately upstream of the ATG is purified.
- the promoter sequence was ligated using DNA ligase T4 (cf. above) the sequence coding for chitinase and the sequence terminator. in the binary vector pBIN 19 (Bevan, 1984, Nucl. Acids Res., 12, 8711-8721), opened using the endonucleases Hind III and EcoRI.
- This vector carries two genes for resistance to kanamycin, one can be expressed in bacteria, the other located immediately in upstream of the complete recombinant gene which can be transferred to cells plant.
- the vector obtained is cloned into the strain E. coli HB 101 (Clontech).
- Nicotiana tabacum tobacco cultivated in vitro was infected with Agrobacterium tumefaciens containing the plasmid pBR 20 according to the procedure of Horsch et al., Well known to those skilled in the art (Horsch RB et al., 1985 Science 227, 1229-1231) , the main steps of which are set out below.
- Discs of leaves of axenic tobacco plants Nicotiana tabacum (variety Wisconsin Havana 38) are incubated in a culture of A. tumefaciens hosting the plasmid pBR 20.
- the discs drained on Whatman paper are cultured on culture media in boxes of Petri in order to multiply the transformed cells so as to obtain calluses.
- These calluses are then transferred to medium containing cefotaxime at 500 mg / ml intended to decontaminate plant tissues (elimination of Agrobacterium tumefaciens ) and kanamycin at 100 mg / ml to select the transgenic material.
- the crude protein extracts were prepared from different plant tissues (root, stem, leaf, etc.).
- the tissue fragments were frozen in liquid nitrogen, reduced to powder and stored at -20 ° C.
- the powder was extracted at 4 ° C in the presence 0.1 M ammonium acetate buffer pH 5.2 and subjected to centrifugation at 10,000 g.
- the concentration of total protein was determined on the supernatants, hereinafter called the crude extracts of proteins using the Bradford technique (Bradford, M.M., 1976 Anal. Biochem., 72, 248-254).
- the crude protein extracts are subjected to a Western blot, technique well known to those skilled in the art and described by H. Towbin et al. (Proc. Ntl. Acad. Sci. USA, 76, 1979, 4350-4354).
- the immunodetection of the protein of interest is carried out thanks to a immuniserum containing polyclonal antibodies recognizing the protein hybrid with chitinase activity (cf. EP-493 581, section 5).
- the antigen-antibody complex is then revealed using a streptavidin-biotin system conjugated to alkaline phosphatase with Amersham RPN 23 kit ("Blotting detection kit”), used according to manufacturer's instructions.
- the print obtained shows, for the leaves of tobacco plants transformed by the plasmid pBR 20, the presence of a weight protein apparent molecular of about 26 ⁇ 6kDa recognized by the antibodies polyclonal and absent from the leaves of control tobacco plants.
- This protein has the same apparent molecular weight as the hybrid protein to chitinase activity described in application EP-493,581.
- the vectors pSG 251 and pSG 33 corresponding respectively to the promoters comprising the sequence (B) [vector pSG 33] and the sequence (C) [vector pSG 251] respectively.
- the chimeric gene associating the promoter (complete or truncated) with the coding part of the glucuronidase and the NOS terminator was purified on agarose gel after cleavage with restriction endonucleases Hind III and EcoRI.
- the chimeric gene has been introduced and ligated into the binary vector pBIN19 (Clontech) previously opened at Hind III sites and EcoRI (Section 13).
- Nicotiana tabacum cultivated in vitro was infected with Agrobacterium tumefaciens containing the various constructs described above. The procedure followed is that described in Section 15.
- the glucuronidase activity is the average of the measurements carried out on 10 to 20 independent transformants. In the absence of an inducer, the activity basic glucuronidase of different genotypes is not significantly affected by deletions for constructs ranging from pSG251 to pSG451: it is substantially identical to that of genotypes containing construction pSG123 (fig. 3). On the other hand, for pSG2 constructions, pSG24, pSG3, pSG1, the expression is lower as the length of the promoter is short: the expressions for pSG3 and pSG1 being zero.
- the expression is however unchanged for genotypes containing the constructions pSG29 and pSG23 with respect to the genotypes containing the constructions pSG123.
- the inducibility is systematically lower than that of genotypes containing the pSG123 construction: it is all the more weak that the promoter is short and cancels for plants containing the constructions pSG3 and psG1.
- sequence D [SEQ. ID No. 6] includes "silencer" type information which partially inhibits inducibility of the complete promoter (sequences B + C + D).
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
| - vecteur binaire pBIN 19 | BEVAN et al., 1984, Nucl. Ac. Res., 12. 8711-8721 ; obtenu auprès de Clontech (Palo Alto Californie USA) |
| - vecteur 101.3 | JEFFERSON, 1987, Plant. Molec. Biol.Reporter 5, 387 - 405 obtenu auprès de Clontech |
| - vecteur pBI 221 | " |
| - vecteur pBI 121 | " |
| - Souche Pseudomonas solanacearum | MESSAGE et al., 1978, Proc. 4th Intl. Conf.of Plant Pathogenic Bacteria pp 823-833 |
| - Souche Pseudomonas solanacearum | " |
| GMI 1178 | " |
| - Souche Pseudomonas solanacearum | " |
| K 60 | " |
| - terminateur NOS | terminateur nopaline synthase |
| - vecteur pTZ 19R | obtenu auprès de Pharmacia |
| - souche E. coli MC1061 | MANIATIS et al., 1982, Molecular cloning : A laboratory Manual, Cold Spring Harbor, New-York, obtenue auprès Clontech |
| - souche E. coli HB101 | " |
| - souche Agrobacterium tumefaciens | LBA4404 obtenue auprès de Clontech HOEKEMA et al.. 1983, NATURE. 303, 179-180 ; |
| - souche Agrobacterium rhizogenes | pRIA4 |
| - plante Nicotiana tabacum | Variété Wisconsin Havana 38 : SCHNEIDER M., 1990, Plant Molec. Biol., 14, 935-947 ; |
| - champignon Chalara elegans | RAWLINGS R.E, 1940. Ann. Mo. Bot. Gdn., 27, 561-598 ; |
| - champignon Alternaria brassicae | BAINS et TEWARI, 1987, Physiol. Mol. Plant. Pathol. 30 : 259 ; |
| - plante Nicotiana tabacum | Variété Paraguay 49 obtenue auprès de l'institut du tabac, Bergerac, France. |
| - plante Brassica napus | variétés de printemps Brutor et Westar et lignée d'hiver (lignée de sélection Rustica Semences) |
| - pathogène Rhzizoctonia Solani | ACHARYA et al., 1984, Can. J. Plant. Pathol, 6, 325-328 |
| - plantes de tournesol | genotype 2603B (lignée de sélection, Rustica semences) |
| - maïs | lignée LH 132 |
| - orge | variété GERBEL obtenue auprès de l'Institut National de la Recherche Agronomique (INRA), Paris, France |
- Les souches GMI 1000 et K 60 peuvent être obtenues auprès de la Collection Nationale des Bactéries Phytopathogènes (CNBP) INRA. Pathologie Végétale. Rue Georges MOREL, 49070 BEAUCOUZE, FRANCE
- La souche GMI 1178 peut être obtenue auprès de l'INRA, Pathologie Végétale, Chemin de Borde-Rouge AUZEVILLE BP 27, 31326 CASTANET TOLOSAN Cedex, FRANCE
Les ARN totaux sont alors dosés par spectrophotométrie à 260 nm.
| Composition du milieu TO (pour 1 litre) | |
| NH4 NO3 | 825 mg |
| K NO3 | 950 mg |
| CaCl2, 2H2O | 220 mg |
| Mg SO4, 7H2O | 185 mg |
| KH2 PO4 | 85 mg |
| H3 BO3 | 1 mg |
| Mn SO4, 4H2O | 100 µg |
| Zn SO4, 7H2O | 1 mg |
| Kl | 100 µg |
| AlCl3 | 30 µg |
| NiCl2, 6H2O | 30 µg |
| CuSO4, 5H2O | 30 µg |
| Fe SO4, 7H2O | 27,8 mg |
| Na2 EDTA, 2H2O | 37,2 mg |
| Thiamine | 100 µg |
| Ac. nicotinique | 200 µg |
| Pyridoxine | 1 mg |
| Biotine | 10 µg |
| Panthoténate de Ca | 1 mg |
| Saccharose | 20 g |
| Inositol | 100 mg |
| Mannitol | 80 g |
| Acide 2-[N-Morpholino] ethanesulfonique (MES) | 200 mg |
- pBI 101 (Clontech), constitué de la partie codante de la glucuronidase précédant le terminateur de la nopaline synthase dans le vecteur binaire pBIN 19. Cette construction, dénommée ci-après construction pBI 101, est dépourvue de promoteur.
- pBI 221 (Clontech), constitué d'un fragment de 800 paires de bases du promoteur 35S du virus de la mosaïque du choux fleur inséré devant la partie codante de la glucuronidase dans le vecteur pBI 101. Cette construction sera dénommée ci-après construction pBI 221.
L'analyse des films permet de tirer les conclusions suivantes :
- certaines plantes ne possèdent pas de copies du gène recombinant transféré (absence de signal),
- la plupart des plantes testées contiennent au moins une copie sans réarrangement de la construction : promoteur 246C - séquence codante de la β-glucuronldsse-terminateur NOS, dénommée ci-après construction pSG 246
- certains profils suggèrent qu'il existe des réarrangements internes dans cette construction, mais ces événements sont rares.
Les résultats montrent que :
- les plantes renfermant la construction pBI 101 ne présentent pas d'activité glucuronidase détectable,
- les plantes renfermant la construction pBI 121 présentent une activité glucuronidase comprise entre 5000 et 70 000 pmoles de méthylumbélliférone/min/mg de protéine correspondant à une expression constitutive attendue pour cette construction. Une légère activation de ce promoteur en réponse au stress d'infiltration a été constatée pour certains transformants,
- les plantes contenant la construction pSG246 présentent une activité glucuronidase faible dans les plantes non inoculées, comprise entre 2000 et 5000 pmol/mg de protéine. Une forte induction est mesurée en réponse à l'infection bactérienne, et ce quelle que soit la souche bactérienne utilisée (GMI 1000 ou K60 (Sequeira et al, Physiol. Plant. Pathol., 10, 43, 1977). souche compatible provoquant des symptômes). Le facteur d'induction (rapport entre l'activité mesurée après inoculation et l'activité mesurée avant inoculation) est de l'ordre de 20 fois et les valeurs d'activité dépassent parfois celles obtenues avec les plantes exprimant la construction pBI 121.
- les plantes renfermant la construction pBI 101 ne présentent pas d'activité glucuronidase détectable,
- les plantes transformées par la construction pBI 121 présentent une activité de 12 000 à 60 000 pmoles de méthylumbélliférone/min/mg de protéine. Cette activité varie peu après inoculation,
- les plantes transformées à l'aide de la construction pSG246 présentent une activité glucuronidase faible chez les plantes saines. Cette activité augmente considérablement dans les plantes présentant des symptômes, atteignant des vecteurs de 85 000 pmoles de méthylumbelliferone formée/min/mg de protéine.
| Composition des différents milieux utilisés pour l'obtention de plantes de tournesol transformées | ||||
| Milieux | I | II | III | IV |
| KNO3 | 2500 | 2500 | 1900 | 1900 |
| NH4 NO3 | - | - | 1650 | 1650 |
| CaCl2, 2H2O | 150 | 150 | 440 | 440 |
| MgSO4,7H2O | 250 | 250 | 370 | 370 |
| KH2 PO4 | - | - | 170 | 170 |
| (NH4)2 SO4 | 134 | 134 | - | - |
| NaH2PO4,H2O | 150 | 150 | - | - |
| ZnSO4,7H2O | 2 | 2 | 8,6 | 8,6 |
| H3 BO3 | 3 | 3 | 6,2 | 6,2 |
| KI | 0,75 | 0,75 | 0,83 | 0,83 |
| CuSO4,5H2O | 0,025 | 0,025 | 0,025 | 0,025 |
| Na2MoO4,2H2O | 0,25 | 0,25 | 0,25 | 0,25 |
| CoCl2, 6H2O | 0,025 | 0,025 | 0,025 | 0,025 |
| Mn SO4, 4H2O | 10 | 10 | 22,3 | 22,3 |
| Na2 EDTA | 37,3 | 37,3 | 37,3 | 37,3 |
| FeSO4 ,7H2O | 27,8 | 27,8 | 27,8 | 27,8 |
| Ac. nicotinique | 1 | - 1 | 0,5 | 0,5 |
| Thiamine HCl | 10 | 10 | 0,1 | 0,1 |
| Pyridoxine HCl | 1 | 1 | 0,1 | 0,5 |
| Myo-inositol | 4000 | 4000 | 100 | 100 |
| L-glycine | - | - | - | 2 |
| L-alanine | 1000 | 1000 | - | - |
| L-glutamine | 800 | 800 | - | - |
| L-serine | 160 | 160 | - | - |
| L-tryptophane | 50 | 50 | - | - |
| L-cystéine | 10 | 10 | - | - |
| Ca-D-panthoténate | - | - | 0.8 | - |
| Ac. folique | - | - | 0.1 | - |
| Chl. de choline | - | - | 0,1 | - |
| Ac p-Aminobenzoïque | - | - | 0.05 | - |
| Riboflavine | - | - | 0.05 | - |
| Saccharose | 120 000 | 60 000 | 30 000 | 30 000 |
| Ac.Dichloro-2-4-phenoxyacétique | 2 | - | - | - |
| 6-Benzylaminopurine | - | 0.4 | - | - |
| Kinétine | - | - | 1 | - |
| Ac.indoleacetique | - | - | - | 0,05 |
| Agar | 7000 | 7000 | 7000 | 8000 |
| pH | 5.7 | 5.8 | 5.7 | 5.7 |
| Milieu d'induction de cals de Maïs à partir d'embryons immatures (en mg pour 1 litre) | |
| MgSO4, 7H2O | 370 |
| CaCl2, 2H2O | 440 |
| KNO3 | 1 900 |
| NH4NO3 | 1 650 |
| KH2PO4 | 170 |
| Na2MoO4, 2H2O | 0,25 |
| CuSO4, 5H2O | 0,025 |
| MnSO4, H2O | 16,75 |
| H3BO3 | 6,2 |
| ZnSO4, 7H2O | 8,6 |
| KI | 0,83 |
| CoCl2, 6H2O | 0,025 |
| FeEDTA | 65,1 |
| Saccharose | 20 000 |
| Hydrolysat de caséine | 100 |
| L-proline | 5 800 |
| Glycine | 2 |
| Acide nicotinique | 0,5 |
| Pyridoxine HCl | 0,5 |
| Inositol | 100 |
| Thiamine HCl | 0,1 |
| Acide abscissique | 0,06 |
| Chloramben | 4,12 |
| Phytagel | 3000 |
| pH = 5.7 Autoclavage 20 min à 120°C |
| Milieu d'entretien des cals de Maïs (en mg pour 1 litre) | |
| MgSO4, 7H2O | 370 |
| CaCl2, 2H2O | 440 |
| KNO3 | 1 900 |
| NH4NO3 | 1 650 |
| KH2PO4 | 170 |
| Na2MoO4, 2H2O | 0,25 |
| CuSO4, 5H2O | 0,025 |
| MnSO4, H2O | 16,75 |
| H3BO3 | 6,2 |
| ZnSO4, 7H2O | 8,6 |
| KI | 0,83 |
| CoCl2, 6H2O | 0,025 |
| FeEDTA | 65,1 |
| Saccharose | 20 000 |
| Hydrolysat de caséine | 100 |
| L-proline | 2 900 |
| Glycine | 2 |
| Acide nicotinique | 0,5 |
| Pyridoxine HCl | 0,5 |
| Inositol | 100 |
| Thiamine HCl | 0,1 |
| Dicamba (Banvel®) | 0,002 |
| Gelrite | 3 000 |
| pH = 5,7 Autoclavage 20 min à 120°C |
| Délétions successives de pSG123 | Activité GUS (pMoles/min/mg) |
| Témoin | 0 |
| pBI221 | ≈ 1000 |
| pSG123 | 5000 |
| pSG251 | 29000 |
| PSG33 | 31000 |
| PSG29 | 26000 |
| PSG23 | 22000 |
| pSG451 | 10000 |
| pSG2 | 4000 |
| PSG14 | 1000 |
| pSG3 | 0 |
| pSG1 | 0 |
Claims (8)
- Utilisation d'un promoteur selon l'une quelconque des revendications 1 à 3, pour obtenir en situation de stress, la surexpression dans un végétal d'une protéine d'intérêt , cette protéine pouvant être destinée à aider les végétaux à surmonter un état de stress.
- Cellules végétales, à l'exception des cellules végétales présentes à l'état naturel, microorganismes (bactéries) ou cellules de microorganismes ayant intégré une unité d'expression d'une protéine comprenant le promoteur végétal selon l'une quelconque des revendications 1 à 3.
- Végétal ou partie de végétal, caractérisé en ce qu'il comprend des cellules végétales selon la revendication 5.
- Semence caractérisée en ce qu'elle comprend des cellules végétales selon la revendication 5.
- Utilisation d'un végétal ou d'une partie de végétal selon les revendications 6 et 7 pour sélectionner des molécules à activité phytosanitaire susceptibles d'induire des réactions de défense naturelles des végétaux contre des organismes phytopathogènes ou phytophages (champignons, bactéries, virus, insectes et nématodes).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9303299 | 1993-03-23 | ||
| FR9303299A FR2703054B1 (fr) | 1993-03-23 | 1993-03-23 | Promoteur vegetal inductible au stress et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur. |
| PCT/FR1994/000316 WO1994021793A1 (fr) | 1993-03-23 | 1994-03-23 | Promoteur vegetal, microorganismes et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0689595A1 EP0689595A1 (fr) | 1996-01-03 |
| EP0689595B1 true EP0689595B1 (fr) | 2003-10-15 |
Family
ID=9445232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP94911205A Expired - Lifetime EP0689595B1 (fr) | 1993-03-23 | 1994-03-23 | Promoteur vegetal, microorganismes et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5792932A (fr) |
| EP (1) | EP0689595B1 (fr) |
| AT (1) | ATE252152T1 (fr) |
| AU (1) | AU6378994A (fr) |
| DE (1) | DE69433238T2 (fr) |
| ES (1) | ES2210251T3 (fr) |
| FR (1) | FR2703054B1 (fr) |
| WO (1) | WO1994021793A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE278027T1 (de) * | 1996-02-01 | 2004-10-15 | Ca Minister Agriculture & Food | Promotor aus tabak |
| FR2775001B1 (fr) * | 1998-02-13 | 2000-05-12 | Lvmh Rech | Acide nucleique comprenant la sequence d'un promoteur inductible par un stress et une sequence d'un gene codant pour une stilbene synthase, cellule et plante transformees par cet acide nucleique |
| FR2775000B1 (fr) * | 1998-02-13 | 2002-02-08 | Lvmh Rech | Promoteur inductible dans les plantes, sequence incorporant ce promoteur et produit obtenu |
| US7094953B2 (en) | 1998-05-29 | 2006-08-22 | Iowa State University Research Foundation, Inc. | Plant retroelements and methods related thereto |
| US6720479B1 (en) * | 1998-05-29 | 2004-04-13 | Iowa State University Research Foundation, Inc. | Plant retroelements and methods related thereto |
| US6774282B1 (en) | 1999-03-08 | 2004-08-10 | Pioneer Hi-Bred International, Inc. | Maize metallothionein gene and promoter |
| US7122721B1 (en) | 1999-10-05 | 2006-10-17 | Basf Aktiengesellschaft | Plant gene expression under the control of constitutive plant V-ATPase promoters |
| US7119192B2 (en) * | 2002-12-26 | 2006-10-10 | Bio-Oriented Technology Research Advancement Institution | Stress-induced promoter derived from rice |
| CN1795267B (zh) * | 2003-03-24 | 2010-10-06 | 独立行政法人国际农林水产业研究中心 | 胁迫-诱导的启动子及其使用方法 |
| US9580695B2 (en) * | 2004-12-23 | 2017-02-28 | Philip Morris Usa Inc. | Reduction of tobacco-specific nitrosamines using genetic modification to elevate production of native antioxidants in tobacco |
| RU2014151361A (ru) * | 2012-05-18 | 2016-07-10 | Пайонир Хай-Бред Интернэшнл, Инк. | Последовательности индуцируемого промотора для регулируемой экспрессии и способы применения |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9000773A (nl) * | 1990-04-02 | 1991-11-01 | Rijkslandbouwhogeschool | Werkwijze voor het beschermen van planten tegen pathogenen. |
| CA2132323A1 (fr) * | 1992-03-20 | 1993-09-30 | Gunter Strittmatter | Gene chimerique a propriete antifongique |
-
1993
- 1993-03-23 FR FR9303299A patent/FR2703054B1/fr not_active Expired - Lifetime
-
1994
- 1994-03-23 WO PCT/FR1994/000316 patent/WO1994021793A1/fr not_active Ceased
- 1994-03-23 US US08/525,507 patent/US5792932A/en not_active Expired - Lifetime
- 1994-03-23 ES ES94911205T patent/ES2210251T3/es not_active Expired - Lifetime
- 1994-03-23 AT AT94911205T patent/ATE252152T1/de not_active IP Right Cessation
- 1994-03-23 AU AU63789/94A patent/AU6378994A/en not_active Abandoned
- 1994-03-23 EP EP94911205A patent/EP0689595B1/fr not_active Expired - Lifetime
- 1994-03-23 DE DE69433238T patent/DE69433238T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU6378994A (en) | 1994-10-11 |
| EP0689595A1 (fr) | 1996-01-03 |
| US5792932A (en) | 1998-08-11 |
| ATE252152T1 (de) | 2003-11-15 |
| DE69433238T2 (de) | 2004-08-12 |
| ES2210251T3 (es) | 2004-07-01 |
| FR2703054A1 (fr) | 1994-09-30 |
| WO1994021793A1 (fr) | 1994-09-29 |
| FR2703054B1 (fr) | 1995-06-16 |
| DE69433238D1 (de) | 2003-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5689056A (en) | HMG2 promoter expression system | |
| US8058422B2 (en) | Tissue specific promoters | |
| CN100535118C (zh) | 百草枯抗性基因及维管束和毛状体特异性启动子 | |
| Machado et al. | The Physcomitrella patens unique alpha-dioxygenase participates in both developmental processes and defense responses | |
| US20170002374A1 (en) | Materials, systems, organisms, and methods for enhancing abiotic stress tolerance, increasing biomass, and/or altering lignin composition | |
| EP0689595A1 (fr) | Promoteur vegetal, microorganismes et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur | |
| FR2674538A1 (fr) | Adn recombinant codant pour une nouvelle proteine a activite beta 1,3-glucanase bacteries contenant cet adn, cellules vegetales et plantes transformees. | |
| JP2002540793A (ja) | 病原体誘導性プロモーター | |
| Chen | Effective reduction of chimeric tissue in transgenics for the stable genetic transformation of Lesquerella fendleri | |
| EP0672124B1 (fr) | Utilisation d'une sequence d'adn codant pour une proteine susceptible de degrader l'acide oxalique a titre de gene de selection | |
| Gu et al. | Agrobacterium-mediated transformation of the winter jujube (Zizyphus jujuba Mill.) | |
| AU731525B2 (en) | Nematode-inducible regulatory DNA sequences | |
| JP2003513608A (ja) | イソコリスミ酸シンターゼおよび植物における耐性の誘導のためのその使用 | |
| JP2004504031A (ja) | リポキシゲナーゼ遺伝子、プロモーター、シグナルペプチド、およびそのタンパク質 | |
| US7041815B2 (en) | Sporamin promoter and uses thereof | |
| Miao et al. | Genetic Transformation of Cotton with the Harpin-Encoding Gene hpa Xoo of Xanthomonas oryzae pv. oryzae and Evaluation of Resistance Against Verticillium Wilt | |
| CA2158960C (fr) | Promoteur de plantes, micro-organismes et cellules de plantes contenant une unite pour l'expression d'une proteine interessante, comprenant ledit promoteur | |
| EP1121451B1 (fr) | Procede d'obtention de plantes transgeniques exprimant une proteine a activite productrice de peroxyde d'hydrogene par transformation par agrobacterium rhizogenes | |
| CN118185984A (zh) | 烟草NtMYC2基因在烟草青枯病抗性和叶宽调控中的应用 | |
| FR2811680A1 (fr) | Promoteur inductible de lipoxygenase, cassettes d'expression le comprenant et plantes transformees | |
| Tewari | Differential expression patterns of the pathogenesis-related PR10 multigene family in Pisum and Lathyrus | |
| MEHARI | PLANTS WITH DEFENSE REGULATORY GENE NPR1 FOR IMPROVING ALTERNARIA RESISTANCE | |
| Xue | Physiological and molecular studies of ethylene effects on soybean root infection by soybean cyst nematodes | |
| ACHARYA | ifHasftet of Science | |
| FR2805825A1 (fr) | Procede de transformation in planta par agrobacterium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19950922 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TOPPAN, ALAIN Inventor name: SCHNEIDER, MICHEL Inventor name: ROBY, DOMINIQUE Inventor name: MARCO, YVES |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIOGEMMA |
|
| 17Q | First examination report despatched |
Effective date: 20000803 |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20031015 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031015 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031015 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ARNOLD & SIEDSMA AG |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: FRENCH |
|
| REF | Corresponds to: |
Ref document number: 69433238 Country of ref document: DE Date of ref document: 20031120 Kind code of ref document: P |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040115 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040115 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040115 |
|
| GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20040126 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040323 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040331 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2210251 Country of ref document: ES Kind code of ref document: T3 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20040716 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040315 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: BIOGEMMA Free format text: BIOGEMMA#1, RUE EDOUARD COLONNE#75001 PARIS (FR) -TRANSFER TO- BIOGEMMA#1, RUE EDOUARD COLONNE#75001 PARIS (FR) |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20120301 Year of fee payment: 19 Ref country code: FR Payment date: 20120410 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20120223 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20120223 Year of fee payment: 19 Ref country code: GB Payment date: 20120224 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20120224 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20120309 Year of fee payment: 19 |
|
| BERE | Be: lapsed |
Owner name: *BIOGEMMA Effective date: 20130331 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20131001 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20130323 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20131129 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 69433238 Country of ref document: DE Effective date: 20131001 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130323 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131001 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130402 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130331 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130331 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130331 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131001 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20140606 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130324 |
























